You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 4,605,671


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,605,671
Title: Parenteral formulation
Abstract:Ready-to-use parenteral formulations of Dezocine containing from about 0.2 to about 2.0 percent wt/vol. Dezocine; about 30 to about 45 percent wt/vol. propylene glycol; about 0.5 to about 2.0 percent wt/vol. lactic acid buffered with a pharmaceutically acceptable base to a pH of from about 3.5 to about 5.0 and 0 to 0.02 percent wt/vol. sodium metabisulfite, in water for injection.
Inventor(s): DeYoung; Joyce L. (Wayne, PA)
Assignee: American Home Products Corporation (New York, NY)
Application Number:06/757,992
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,605,671

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its significance and implications. This article will provide a detailed analysis of United States Patent 4,605,671, focusing on its claims, scope, and the context within which it exists.

Patent Overview

United States Patent 4,605,671, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and search tools available through the USPTO.

Patent Search and Retrieval

To begin, one would use the USPTO's Patent Public Search tool or other resources like the Patent and Trademark Resource Centers (PTRCs) to retrieve the patent details. The Patent Public Search tool offers enhanced access to prior art and allows users to select from modern interfaces, improving the overall search process[1].

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim. The scope of a patent is largely determined by its claims, and metrics such as independent claim length and count can provide insights into the patent's breadth and clarity[3].

Claim Validity

The validity of patent claims is often a point of contention. For instance, under 35 U.S.C. § 101, claims must be directed to patent-eligible subject matter and must not be abstract ideas without an inventive step. The court's decision in cases like AI Visualize, Inc. v. Nuance Communications, Inc. highlights the importance of ensuring claims meet these criteria to avoid being deemed invalid[2].

Scope of the Patent

Patent Scope Metrics

The scope of a patent can be measured using various metrics. Independent claim length and count are simple yet effective measures. Narrower claims at publication are often associated with a higher probability of grant and a shorter examination process, indicating better clarity and validity[3].

Patent Classes and Forward Citations

The breadth of patent classes and the number of forward citations can also indicate the scope and impact of a patent. Patents with broader classes and more forward citations generally have a wider scope and greater influence on subsequent inventions.

Patent Landscape

Prior Art and Citation Data

Understanding the prior art and citation data is crucial. Tools like the Common Citation Document (CCD) consolidate citation data from multiple IP offices, helping to visualize the prior art landscape for a patent family. This can provide insights into how the patent fits within the broader technological landscape[1].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices. This can help in understanding the global context and the family of patents related to the one in question[1].

Legal and Policy Considerations

Patent Eligibility

The eligibility of a patent under 35 U.S.C. § 101 is a critical legal consideration. Courts often review claims to ensure they are not directed to abstract ideas or natural phenomena without a sufficient inventive step. This legal framework is essential in defining the scope and validity of a patent[2].

Small Claims Patent Court

There are ongoing discussions and studies about the feasibility of a small claims patent court, which could impact how patent disputes are resolved, especially for smaller entities. This could potentially affect the enforcement and scope of patents like 4,605,671 in future legal proceedings[5].

Practical Implications

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation costs. Patents with overly broad claims or decreased clarity may diminish innovation incentives due to increased costs associated with licensing and litigation[3].

Business Applications

Understanding the scope and claims of a patent is vital for businesses looking to innovate or protect their inventions. It helps in identifying potential areas for improvement, avoiding infringement, and leveraging the patent for competitive advantage.

Key Takeaways

  • Claims Analysis: The claims of a patent define its scope and validity.
  • Patent Scope Metrics: Metrics like independent claim length and count can measure patent scope.
  • Prior Art and Citation Data: Tools like CCD help in understanding the prior art landscape.
  • Global Context: Services like Global Dossier provide insights into the global patent family.
  • Legal Considerations: Ensuring patent eligibility under 35 U.S.C. § 101 is crucial.
  • Practical Implications: The scope and claims impact licensing, litigation, and business strategies.

FAQs

  1. What is the importance of independent claims in a patent? Independent claims define the core of the invention and stand alone without reference to other claims. They are crucial for determining the patent's scope and validity.

  2. How can the scope of a patent be measured? The scope can be measured using metrics such as independent claim length and count, breadth of patent classes, and the number of forward citations.

  3. What is the role of the Common Citation Document (CCD) in patent searching? The CCD consolidates citation data from multiple IP offices, helping to visualize the prior art landscape for a patent family.

  4. Why is patent eligibility under 35 U.S.C. § 101 important? Ensuring patent eligibility under 35 U.S.C. § 101 is crucial to avoid claims being deemed invalid as abstract ideas or natural phenomena without an inventive step.

  5. How might a small claims patent court impact patent enforcement? A small claims patent court could make it easier and less costly for smaller entities to resolve patent disputes, potentially affecting the enforcement and scope of patents.

Sources

  1. USPTO - Search for patents
  2. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.
  3. Patent Claims and Patent Scope - SSRN
  4. D2.3 Successful Scenarios for Ontology-based ... - CiteSeerX
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,605,671

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,605,671

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 4713685 ⤷  Try for Free
Australia 572689 ⤷  Try for Free
Austria 41602 ⤷  Try for Free
Canada 1251402 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.